跳至主要内容
临床试验/NCT00914680
NCT00914680已完成3 期

Investigation of Efficacy and Tolerability of Magnetic Seizure Therapy in the Treatment of Depression

Charite University, Berlin, Germany2 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2009年6月最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
32
试验地点
2
主要终点
Clinical Improvement (HAMD)

研究概览

简要总结

This treatment pilot study will investigate clinical efficacy and adverse effects of magnetic seizure therapy (MST) in patients currently experiencing a unipolar or bipolar depressive episode. The investigators will perform add-on tests to assess clinical and cognitive response to treatment. It is hypothesized that MST will have an antidepressant efficacy with a beneficial neurocognitive adverse effect profile.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
25 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is diagnosed with a severe major depressive episode
  • Patient is in a chronic current MDE and/or has had a history of recurrent MDEs
  • Patient has not had an acceptable clinical response due to failure with at least 2 antidepressant treatments during the current episode
  • Patient has a score > 20 on the HAMD24
  • Patient is stable on current psychotropic medication for at least 4 weeks
  • Patient is > 25 and < 80 years

排除标准

  • Atypical Depression or psychotic depression (according to DSM IV)
  • Other relevant psychiatric axis I or axis II diseases
  • Relevant neurological diseases
  • Relevant cardiac or pulmonary diseases with enhances anesthesiological risk (ASA Score > 3)
  • Patient is currently enrolled in another investigational study not associated with the current study
  • Patient has a history of, or evidence of, significant brain malformation or significant head injury

研究组 & 干预措施

MST

Experimental

干预措施: magnetic seizure therapy (Procedure)

结局指标

主要结局

Clinical Improvement (HAMD)

时间窗: before, after treatment

次要结局

  • Neurocognitive performance(before/after treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Malek Bajbouj

Prof. Dr.

Charite University, Berlin, Germany

研究点 (2)

Loading locations...

相似试验

Berlin Magnetic Seizure Therapy Depression Trial 01 | 临床试验